Literature DB >> 9684647

Trypanosoma cruzi in the rectum of the bug Triatoma infestans: effects of blood ingestion by the starved vector.

A H Kollien1, G A Schaub.   

Abstract

To follow the developmental effects of feeding of the insect host after long starvation periods, the population density and composition of an established infection of Trypanosoma cruzi in the rectum of Triatoma infestans were determined 60 days after the last feeding (daf) and then at different intervals after feeding. The original population decreased and then increased up to the 10th daf. In starved bugs, about 30% were spheromastigotes (including intermediate forms), 20% epimastigotes, and 50% trypomastigotes, but one daf, these forms represented 2%, 70%, and 10%, respectively. In addition, one daf there were about 10% giant cells, i.e., a multiple division stage. In the following two days, this form represented on average 30-50% of the total population, but it then disappeared nearly completely. Thus, giant cells evidently develop by rapid growth of epimastigotes, if conditions become optimal after long starvation periods of the vector.

Entities:  

Mesh:

Year:  1998        PMID: 9684647     DOI: 10.4269/ajtmh.1998.59.166

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Stationary phase in Trypanosoma cruzi epimastigotes as a preadaptive stage for metacyclogenesis.

Authors:  Roberto Hernández; Ana María Cevallos; Tomás Nepomuceno-Mejía; Imelda López-Villaseñor
Journal:  Parasitol Res       Date:  2012-05-31       Impact factor: 2.289

2.  RNA Granules Living a Post-transcriptional Life: the Trypanosomes' Case.

Authors:  Alejandro Cassola
Journal:  Curr Chem Biol       Date:  2011-05

3.  Colchicine treatment reversibly blocks cytokinesis but not mitosis in Trypanosoma cruzi epimastigotes.

Authors:  Mariana Potenza; María Teresa Tellez-Iñón
Journal:  Parasitol Res       Date:  2014-11-20       Impact factor: 2.289

4.  Rhodnius prolixus Life History Outcomes Differ when Infected with Different Trypanosoma cruzi I Strains.

Authors:  Jennifer K Peterson; Andrea L Graham; Andrew P Dobson; Omar Triana Chávez
Journal:  Am J Trop Med Hyg       Date:  2015-06-15       Impact factor: 2.345

5.  Ultrastructural and physiological changes induced by different stress conditions on the human parasite Trypanosoma cruzi.

Authors:  Deyanira Pérez-Morales; Karla Daniela Rodríguez Hernández; Ignacio Martínez; Lourdes Teresa Agredano-Moreno; Luis Felipe Jiménez-García; Bertha Espinoza
Journal:  Cell Stress Chaperones       Date:  2016-10-06       Impact factor: 3.667

6.  Are Members of the Triatoma brasiliensis (Hemiptera, Reduviidae) Species Complex Able to Alter the Biology and Virulence of a Trypanosoma cruzi Strain?

Authors:  J Costa; C A C Araújo; C A V Freitas; J Borges-Pereira
Journal:  Neotrop Entomol       Date:  2015-03-03       Impact factor: 1.434

7.  Trypanosoma cruzi infection in Mepraia gajardoi and Mepraia spinolai: the effect of feeding nymphs from the field.

Authors:  Camila Egaña; Fernanda Vergara; Ricardo Campos; Sylvia Ortiz; Carezza Botto-Mahan; Aldo Solari
Journal:  Am J Trop Med Hyg       Date:  2014-06-16       Impact factor: 2.345

8.  The development of Blastocrithidia triatomae (Trypanosomatidae) in the reduviid bug Triatoma infestans (Insecta): influence of feeding.

Authors:  Astrid H Kollien; Günter A Schaub
Journal:  Parasitol Res       Date:  2002-12-20       Impact factor: 2.289

9.  Differential expression profiles in the midgut of Triatoma infestans infected with Trypanosoma cruzi.

Authors:  Diego S Buarque; Glória R C Braz; Rafael M Martins; Anita M Tanaka-Azevedo; Cícera M Gomes; Felipe A A Oliveira; Sergio Schenkman; Aparecida S Tanaka
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

10.  Actions of a proline analogue, L-thiazolidine-4-carboxylic acid (T4C), on Trypanosoma cruzi.

Authors:  Anahí Magdaleno; Il-Young Ahn; Lisvane Silva Paes; Ariel M Silber
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.